These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 34431629)

  • 21. COVID-19 and diabetes: No time to drag our feet during an untimely pandemic.
    Kyrou I; Robbins T; Randeva HS
    J Diabetes Complications; 2020 Sep; 34(9):107621. PubMed ID: 33051004
    [No Abstract]   [Full Text] [Related]  

  • 22. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.
    D'Onofrio N; Scisciola L; Sardu C; Trotta MC; De Feo M; Maiello C; Mascolo P; De Micco F; Turriziani F; Municinò E; Monetti P; Lombardi A; Napolitano MG; Marino FZ; Ronchi A; Grimaldi V; Hermenean A; Rizzo MR; Barbieri M; Franco R; Campobasso CP; Napoli C; Municinò M; Paolisso G; Balestrieri ML; Marfella R
    Cardiovasc Diabetol; 2021 May; 20(1):99. PubMed ID: 33962629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The agreed experts' position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2].
    Arutiunov GP; Tarlovskaia EI; Koziolova NA; Boldina MV; Batiushin MM; Ametov AS; Arutiunov AG; Belevskii AS; Galstian GR; Grigor'eva NI; Dzhunusbekova GA; Esaian AM; Mal'chikova SV; Mit'kovskaia NP; Mkrtumian AM; Orlova IA; Petrova MM; Rebrov AP; Ruzanov DI; Salukhov VV; Sisakian AS; Skibitskii VV; Sugraliev AB; Fomin IV; Khalimov IS; Chesnikova AI; Shaposhnik II; Shestakova MV
    Ter Arkh; 2020 Oct; 92(9):108-124. PubMed ID: 33346439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations for the care of patients with diabetes mellitus with risk factors or established cardiovascular disease and SARS-CoV-2mellitus con factores de riesgo o enfermedad cardiovascular establecida y SARS-CoV-2.
    Alcocer-Gamba MA; Gutiérrez-Fajardo P; Sosa-Caballero A; Cabrera-Rayo A; Faradji-Hazan RN; Padilla-Padilla FG; Garnica-Cuellar JC; Hernández-Arispe LM; Reyes-Cianeros FA; León-Suárez A; de-Jesús-Rivera J; Mancillas-Adame L; Gaxiola-Macias M; Márquez-Rodríguez E; Miranda-Malpica E; Sanchez-Pedraza V; Lara-Martínez DS; Segovia-Palomo A; Nava-Hernández A; Rivera-Reyes R
    Arch Cardiol Mex; 2020; 90(Supl):77-83. PubMed ID: 32523151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to: Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?
    Lippi G; Sanchis-Gomar F; Henry BM
    J Diabetes; 2021 Feb; 13(2):179-180. PubMed ID: 33128349
    [No Abstract]   [Full Text] [Related]  

  • 26. Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?
    Sathish T; de Mello GT; Cao Y
    J Diabetes; 2021 Feb; 13(2):177-178. PubMed ID: 33107708
    [No Abstract]   [Full Text] [Related]  

  • 27. Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis.
    Dhar SK; Sachdeva K; Das M
    Diabetes Metab Syndr; 2021; 15(2):639-641. PubMed ID: 33676871
    [No Abstract]   [Full Text] [Related]  

  • 28. Editor's Comment. Caution: The Intersection of Diabetes and COVID-19.
    Chernoff A
    Endocr Res; 2021; 46(2):55-56. PubMed ID: 33730984
    [No Abstract]   [Full Text] [Related]  

  • 29. Tuberculosis and Type 2 Diabetes Mellitus: An Inflammatory Danger Signal in the Time of Coronavirus Disease 2019.
    Wilkinson RJ
    Clin Infect Dis; 2021 Jan; 72(1):79-81. PubMed ID: 32533824
    [No Abstract]   [Full Text] [Related]  

  • 30. How might remote management of diabetes mellitus during the COVID-19 pandemic impact patient care?
    Barber TM; Weickert MO
    Expert Rev Endocrinol Metab; 2021 Jul; 16(4):155-158. PubMed ID: 34187276
    [No Abstract]   [Full Text] [Related]  

  • 31. Issues for the management of people with diabetes and COVID-19 in ICU.
    Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P;
    Cardiovasc Diabetol; 2020 Jul; 19(1):114. PubMed ID: 32690029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autonomic dyshomeostasis in patients with diabetes mellitus during COVID-19.
    Boccardi V
    Nat Rev Endocrinol; 2021 Mar; 17(3):189. PubMed ID: 33452491
    [No Abstract]   [Full Text] [Related]  

  • 33. TB and COVID-19: paying attention to diabetes mellitus.
    Harries AD; Kumar AMV; Satyanarayana S; Lin Y; Dlodlo RA; Khogali M; Zachariah R; Kapur A
    Trans R Soc Trop Med Hyg; 2021 Jun; 115(6):600-602. PubMed ID: 34075400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 perturbs the renin-angiotensin system and energy metabolism.
    Mori J; Oudit GY; Lopaschuk GD
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E43-E47. PubMed ID: 32469255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes Mellitus and COVID-19: Unholy Association of Two Pandemics.
    Kamrul-Hasan AB; Nessa A; Debnath CR
    Mymensingh Med J; 2021 Jan; 30(1):1-2. PubMed ID: 33397842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observational research on severe COVID-19 in diabetes.
    Stehouwer CDA
    Lancet Diabetes Endocrinol; 2021 Feb; 9(2):56-57. PubMed ID: 33357490
    [No Abstract]   [Full Text] [Related]  

  • 37. COVID 19 could trigger global diabetes burden - A hypothesis.
    Mukherjee S; Banerjee O; Singh S; Maji BK
    Diabetes Metab Syndr; 2020; 14(5):963-964. PubMed ID: 32604015
    [No Abstract]   [Full Text] [Related]  

  • 38. Microvascular disease in diabetes and severe COVID-19 outcomes.
    Corcillo A; Whyte MB; Vas P; Karalliedde J
    Lancet Diabetes Endocrinol; 2021 Apr; 9(4):200-201. PubMed ID: 33740436
    [No Abstract]   [Full Text] [Related]  

  • 39. [Continuing or stopping metformin in patients with type 2 diabetes exposed to SARS-CoV-2 ?].
    Scheen AJ; Paquot N
    Rev Med Liege; 2021 Mar; 76(3):152-155. PubMed ID: 33682382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remote Glucose Monitoring Platform for Multiple Simultaneous Patients at Coronavirus Disease 2019 Intensive Care Units: Case Report Including Adults and Children.
    Garelli F; Rosales N; Fushimi E; Arambarri D; Mendoza L; De Battista H; Sánchez-Peña R; García Arabehety J; Distefano S; Barcala C; Giunta J; Las Heras M; Martinez Mateu C; Prieto M; San Román E; Krochik G; Grosembacher L
    Diabetes Technol Ther; 2021 Jun; 23(6):471-473. PubMed ID: 33337261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.